I agree. They have years of research, but also treatment history from thousands of patients. They've conducted studies and documented results. Just like you said, the FDA isn't going to waste this time and money on a company that has no revenue growth, because with no revenue, no company will sustain on just investors. The FDA is afraid of how much USRM is going to grow and they are trying to slow them down as much as possible with regulations which would be a huge help to big pharma. Just think of how many more physicians would want training in USRM protocol if they win. The more physicians using USRM protocol and kits will mean company growth and truly help identify USRM as a leader in the industry. USRM is a threat and the FDA/Pharma hate this. My one post for the day.
News 
Market Data 
Discover 
